Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

Abstract The 2013 update of the American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) human epidermal growth factor receptor 2 (HER2) testing guidelines recommend using an alternative chromosome 17 probe assay to resolve HER2 results determined to be equivocal by immunohi...

Full description

Bibliographic Details
Main Authors: Neelam V. Desai, Vanda Torous, Joel Parker, James T. Auman, Gary B. Rosson, Cassandra Cruz, Charles M. Perou, Stuart J. Schnitt, Nadine Tung
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Breast Cancer Research
Subjects:
HER2-positive breast cancer
PAM50 intrinsic subtype
HER2 alternative probe
ASCO-CAP guidelines
Online Access:http://link.springer.com/article/10.1186/s13058-018-1005-z

Internet

http://link.springer.com/article/10.1186/s13058-018-1005-z

Similar Items